Soleil Moon Frye and Cherie Johnson talk to Yahoo Entertainment about the new Punky Brewster reboot, premiering Feb. 25 on Peacock. Frye and Johnson also look back on Andy Gibb's guest starring role.
Soleil Moon Frye and Cherie Johnson talk to Yahoo Entertainment about the new Punky Brewster reboot, premiering Feb. 25 on Peacock. Frye and Johnson also look back on Andy Gibb's guest starring role.
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel treatments for neurological and kidney diseases, today announced that Dr. Harry Alcorn, its Chief Medical Officer will be presenting "CKD DM199 Research Update" at the 3rd Chronic Kidney Disease Drug Development ("CKD3") summit virtually on Tuesday March 2nd, 2021, at 1:00pm Eastern Time. The presentation will include data from the CKD Phase 1b study and an overview of the CKD Phase II Redux study design.
The news could be a boost to pubs that don't have outdoor areas with lockdown set to ease.
Orders to U.S. factories for big-ticket goods shot up 3.4% in January, pulled up by surge in orders for civilian aircraft. A category that tracks business investment posted a more modest gain, the Commerce Department rpeorted Thursday. Orders for civilian aircraft and parts jumped 389.9%.
Bill Michael resigned earlier this month after details of a conference call were leaked to the press.
The MEA aircraft floor panel market is expected to grow from US$ 33. 96 million in 2019 to US$ 47. 63 million by 2027; it is estimated to grow at a CAGR of 5. 4% from 2020 to 2027. Increasing demand for air freighter fleet across the MEA region is expected to upswing the MEA aircraft floor panel market.New York, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "South America Aircraft Floor Panel Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Aircraft Type, Material Type, Sales Channel, and End User" - https://www.reportlinker.com/p06004227/?utm_source=GNW The MEA air freight business is surging at an exponential rate, thereby driving the orders and shipment of freighter aircraft models across the MEA region.The wide body freighters dominated the air freight industry over the years, thus boosting the procurement volumes of aircraft floor panels.The flooring of any freighter aircraft is manufactured with ultimate precaution and accuracy, as the floor panels need to carry heavier loads than passenger aircraft cargo compartments.Moreover, the strength and rigidity of these floor panels is of utmost importance.Several cargo carriers are procuring narrow body freighters and are also converting the existing narrow body passenger aircraft to freighter aircraft.The Boeing B737 series aircraft fleet is also anticipated to experience strong demand for passenger-to-freighter conversion, which would allow the MEA several aircraft floor panel market players and aftermarket players to witness higher demand for their products and services. These developments would propel the MEA aircraft floor panel market in the coming years. Increasing need for air freighter fleet would surge the demand of aircraft floor panels in coming years, thereby driving the MEA aircraft floor panel market.The MEA, especially the UAE and Iran, is highly affected due to the COVID-19 outbreak.The MEA aircraft floor panels market is majorly affected by the disruption in the supply chain.Pertaining to the closure of countries’ borders, the supply chain of several components and parts has been disturbed.The demand for advanced aircraft components, including aircraft floor panels for line fitting and retrofitting activities on military aircraft fleet and general aviation fleet among the aircraft manufacturers, military forces, and MRO service providers, has weakened over the past couple of months.This has resulted in the loss of business among the aircraft floor panel market players offering their products to respective customers in the MEA region.Additionally, several airlines have postponed or canceled the procurement or orders of scheduled aircraft.The COVID-19 outbreak has led the manufacturers to suspend their operations or operate with a minimal workforce temporarily. This has weakened the demand for aircraft floor panels, thereby hindering the country’s aircraft floor panel market.Based on aircraft type, the wide body aircraft segment led the MEA aircraft floor panel market in 2019.A wide body aircraft has the capability to carry ~200-850 passengers and is used to operate long-haul and medium-haul flights.In the MEA region, the air passenger traffic has been surging with time.Hence, rather than operating small airplanes, a larger one that has the ability to carry a large number of passengers at once is preferred.Therefore, this trend is projected to compel the demand for wide body aircraft floor panels during the forecast period for the MEA region.The wide body aircraft provides airlines the opportunity to deliver better customer experience through value-added services.Rising initiations by the governments across the MEA region for the aerospace & defense industry are likely to push the demand for wide body aircraft in the near future, which would also push the demand for aircraft floor panels. Wide body aircraft has larger surface areas that require wide floor panel system, which are equipped to the aircraft’s floor beams in order to offer a surface for crew and passengers to walk on and also provide attachment points for furnishings and other components. The powerful floor panels act as a supporting structure, which is light enough to keep aircraft weight low. Advantages of aircraft floor panels, such as light weight, high durability, and strength, are expected to increase their demand for wide body aircraft, which would drive the MEA aircraft floor panel market.The overall MEA aircraft floor panel market size has been derived using both primary and secondary sources.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the MEA aircraft floor panel market.The process also serves the purpose of obtaining overview and forecast for the MEA aircraft floor panel market with respect to all the segments pertaining to the region.Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic.The participants who typically take part in such a process include industry experts, such as VPs, business development managers, aircraft floor panel market intelligence managers, and national sales managers, along with external consultants, such as valuation experts, research analysts, and key opinion leaders specializing in the MEA aircraft floor panel market. Aim Altitude UK Ltd.; Collins Aerospace, a Raytheon Technologies Corporation company; Euro Composite S.A.; Safran S.A; Singapore Technologies Engineering Ltd; and The Gill Corporation are among a few players operating in the MEA aircraft floor panel market.Read the full report: https://www.reportlinker.com/p06004227/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
There were 2,688 people estimated to be sleeping rough on any single night in England over the autumn, Government figures show.
REDWOOD CITY, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will present at the following investor conferences in March. 41st Annual Cowen Healthcare Conference on Monday, March 1 at 4 p.m. ETBarclays Global Healthcare Conference on Tuesday, March 9 at 1:15 p.m. ET The audio portion of the presentation will be available on the investors’ page of the Coherus BioSciences website at http://investors.coherus.com. About Coherus BioSciences Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. For additional information, please visit www.coherus.com. ContactMcDavid StilwellEVP, Financial Strategy and IRCoherus BioSciences, Inc.email@example.com+1 (650) 395-0152
Barnes & Noble Education, Inc. (NYSE: BNED), a leading solutions provider for the education industry, today announced findings from its latest research report, COLLEGE 2030™: Transforming the Student Experience. Featuring insights from college students, faculty members and campus administrators, the report provides a comprehensive view of the current state of higher education and an exclusive outlook on the decade ahead.
USD 297,400,000 Senior Unsecured Convertible Bonds due 2024 Notice to Bondholders BW Offshore Limited USD 297,400,000 Senior Unsecured Convertible Bonds due 2024 (the Bonds”)(ISIN: NO0010867948) Capitalised terms not otherwise defined herein shall have the meanings given to them in the terms and conditions of the Bonds (the “Bond Terms”). In accordance with the Bond Terms, BW Offshore Limited as the Issuer hereby gives notice to Bondholders that, as a result of the Dividend of USD 0.035 payable to Shareholders of record on 26 February 2021, pursuant to Clause 13.1(iii) and Clause 13.6, the Conversion Price has been adjusted from USD 9.1029 to USD 8.9479, effective as of 25 February 2021. For further information, please contact:Ståle Andreassen, CFO, +65 97 27 86 47Anders S. Platou, Head of Corporate Finance, +47 99 50 47 40 About BW Offshore:BW Offshore engineers innovative floating production solutions. The Company has a fleet of 15 FPSOs with potential and ambition to grow. By leveraging four decades of offshore operations and project execution, the Company creates tailored energy solutions for evolving markets world-wide. BW Offshore has around 2,000 employees and is publicly listed on the Oslo Stock Exchange. This information is subject to a duty of disclosure pursuant to Section 5-12 of the Norwegian Securities Trading Act.
GRAX, the leading SaaS Data Value Platform, announced today that it has elected Morten Bagai to its board of directors. Bagai is the Chief Technology Officer of GRAX.
ROCHESTER, N.Y., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (NYSE American: DSS) (“DSS”), a multinational company operating businesses in brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced the expansion of its DSS Securities, Inc. business through an equity interest in WestPark Capital, Inc.(“WestPark”) and an investment in BMI Capital International LLC (“BMI”). “This is a major milestone that falls directly in line with our plans to fill out the ecosystem around DSS Securities and builds upon our recently announced collaboration to develop a digital securities exchange business in the US,” stated Frank D. Heuszel, CEO of DSS. DSS executed two separate transactions designed to grow its DSS Securities division, signing a binding note and stock exchange letter of intent to own 7.5% of the issued and outstanding shares of WestPark and acquiring 24.9% of BMI through a purchase agreement. “We have participated in the blockchain space since its earliest days,” commented Richard Rappaport, Chairman and Founder of WestPark. “DSS Securities is extremely well positioned in the industry with its recent JV with Coinstreet Partners and GSX Group, and we believe this is the beginning of a lasting, mutually rewarding relationship.” WestPark is a full-service investment banking and securities brokerage firm which serves the needs of both private and public companies worldwide, as well as individual and institutional investors. BMI is a private investment bank specializing in corporate finance advising, raising equity, and venture services, providing a global “one-stop” corporate consultancy to listed companies. From corporate finance to professional valuation, corporate communications to event management, BMI services companies in the US, Hong Kong, Singapore, Taiwan, Japan, Canada, and Australia. “Change is constant in the markets,” added Robert Trapp, CEO of BMI. “We are excited to work with DSS Securities as they capitalize on the wealth of opportunities presented by the latest seismic shifts revolutionizing the securities industry.” Heuszel continued, “The transformative potential of digital securities is extremely exciting. Working closely with WestPark and BMI, we can tap into established channels to accelerate the development of a secondary market in securities tokens, what we believe will be the next evolutionary stage in capital markets development.” “This is a great opportunity that provides a conduit to propel widespread interest in our digital security exchange,” added Jason Grady, COO of DSS. “We plan to continue to invest in these and other similar ventures as opportunities warrant, effectively allocating the capital we have available to drive growth and maximize returns.” Regulated digital securities exchanges provide a single point of access to issuance, listing, trading, and settlement of digital securities for public and private companies issuing equities, debt, investment funds, real estate, and commodities. In addition to providing an alternative to current public markets, digital securities exchanges are positioned to tap into the $6.5 trillion private company market, which is estimated to be growing 2x faster than public markets. About Document Security Systems, Inc. DSS is a multinational company, operating businesses in brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. Its historic business revolves around counterfeit deterrent and authentication technologies, smart packaging, and consumer product engagement. DSS is led by its Chairman and largest shareholder, Mr. Fai Chan, a highly successful global business veteran of more than 40 years specializing in corporate transformation while managing risk. He has successfully restructured more than 35 corporations with a combined value of $25 billion. For more information on DSS visit http://www.dsssecure.com. DSS Investor Contact:Dave Gentry, CEORedChip Companies Inc.407-491-4498Dave@redchip.com Safe Harbor Disclosure This press release contains forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements related to the Company's intended use of proceeds and other statements that are not historical facts. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that may cause actual results or events to differ materially from those projected. These risks and uncertainties, many of which are beyond our control, include: risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; risks relating to the results of development activities; our ability to attract, integrate and retain key personnel; our need for substantial additional funds; patent and intellectual property matters; competition; as well as other risks described in the section entitled "Risk Factors" in the prospectus and in our other filings with the SEC, including, without limitation, our reports on Forms 8-K and 10-Q, all of which can be obtained on the SEC website at www.sec.gov. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management's current estimates, projections, expectations and beliefs. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.
European Subsea Cables Conference - Call for Papers
Of 27 patients who completed interval debulking surgery, 80% of those treated with GEN-1 had an R0 resection compared with 58% of control patients, a 38% improvement To date 34 patients, or approximately one-third of the total, have been enrolled at 22 sites, including 20 patients in the treatment arm and 14 patients in the control arm LAWRENCEVILLE, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today provided an update on its Phase I/II OVATION 2 Study with GEN-1 in patients with advanced ovarian cancer, including interim observations. GEN-1 is Celsion’s DNA-mediated interleukin-12 (IL-12) immunotherapy designed using TheraPlas, its proprietary, synthetic, non-viral nanoparticle delivery system platform. The OVATION 2 Study combines GEN-1 with standard-of-care neoadjuvant chemotherapy (NACT) in patients newly diagnosed with Stage III/IV ovarian cancer. NACT is designed to shrink the cancer as much as possible for optimal surgical removal after three cycles of chemotherapy. Following NACT, patients undergo interval debulking surgery, followed by three adjuvant cycles of chemotherapy and up to nine additional weekly GEN-1 treatments, the goal of which is to delay progression and improve overall survival. The OVATION 2 Study is an open-label, 1-to-1 randomized trial, 80% powered to show the equivalent of a 33% improvement in progression-free survival (PFS) (HR=0.75), the primary endpoint, when comparing the treatment arm (standard of care + GEN-1) with the control arm (standard of care alone). To date, the Company has enrolled approximately one-third, or 34 patients, of the anticipated 110 patients to be enrolled into the OVATION 2 Study, of which 20 are in the treatment arm and 14 are in the control. Currently, 27 patients have had their interval debulking surgery with the following results: 12 of 15, or 80%, of patients treated with GEN-1 had a R0 resection, which indicates a microscopically margin-negative complete resection in which no gross or microscopic tumor remains in the tumor bed.7 of 12 patients, or 58%, of patients in the control arm had an R0 resection.This interim data represents a 38% improvement in R0 resection rates for GEN-1- patients compared with control arm patients and is consistent with the reported improvement in resection scores noted in the encouraging Phase I OVATION I Study, the manuscript of which has been submitted for peer review publication. “As the goal for surgical debulking is to eliminate microscopic disease, more ovarian cancer patients require neoadjuvant chemotherapy. However, little progress has been made in adding additional efficacious immunotherapy agents to standard neoadjuvant chemotherapy,” said Premal H. Thaker, M.D., MSc., Professor in Gynecologic Oncology and Director of Gynecologic Oncology Clinical Research at Washington University School of Medicine in St. Louis and lead Principal Investigator for the OVATION 2 Study. “The results seen to date in the OVATION 2 Study are exciting and impactful for ovarian cancer patients.” The Company further reports that 22 clinical sites in the U.S. and Canada have been initiated, with three more sites expected to be added by the end of the first quarter. Clinical investigators met in early February in a virtual meeting and expressed excitement about the potential for GEN-1 to treat advanced ovarian cancer and, despite the challenges and earlier delays posed by the COVID-19 pandemic, they remain committed to completing enrollment in the study during the second half of 2021. Commenting on the interim patient reports, Dr. Nick Borys, chief medical officer of Celsion, said, “We are gratified that such a high proportion of GEN-1 patients had no residual disease at the time of their debulking surgery. These results are consistent with what we observed in our Phase I (OVATION I) study. This is great news for the patients and the surgeons in our study as a R0 resection suggests a good clinical outcome. We are following our patients carefully to see how well they do long term. The OVATION 2 investigators remain enthusiastic about the potential of GEN-1 to treat late-stage ovarian cancer, which currently has few treatment options.” Celsion announced earlier this week that GEN-1 had received Fast Track designation from the U.S. Food and Drug Administration (FDA). This designation is intended to facilitate the development and expedite the regulatory review of drugs to treat serious conditions and fill an unmet medical need. According to the FDA, a Fast Track Drug must show some advantage over available therapy, including: Showing superior effectiveness, effect on serious outcomes or improved effect on serious outcomesAvoiding serious side effects of an available therapyDecreasing a clinically significant toxicity of an available therapy that is common and causes discontinuation of treatment About GEN-1 Immunotherapy GEN-1, designed using Celsion's proprietary TheraPlas platform technology, is an IL-12 DNA plasmid vector encased in a nanoparticle delivery system, which enables cell transfection followed by persistent, local secretion of the IL-12 protein. IL-12 is one of the most active cytokines for the induction of potent anti-cancer immunity acting through the induction of T-lymphocyte and natural killer (NK) cell proliferation. The Company has previously reported positive safety and encouraging Phase I results with GEN-1 given as monotherapy or a combination therapy in patients with advanced peritoneally metastasized primary or recurrent ovarian cancer, and recently completed a Phase Ib dose-escalation trial (OVATION 1 Study) of GEN-1 in combination with carboplatin and paclitaxel in patients with newly diagnosed ovarian cancer. About Celsion Corporation Celsion is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including immunotherapies and DNA-based therapies; and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV2. The company’s product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored development for several cancer indications. Celsion also has two feasibility stage platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies. Both are novel synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection. For more information on Celsion, visit www.celsion.com. Forward-looking Statements Forward-looking statements in this news release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are subject to a number of risks and uncertainties, many of which are difficult to predict, including, unforeseen changes in the course of research and development activities and in clinical trials; the uncertainties of and difficulties in analyzing interim clinical data, particularly in small subgroups that are not statistically significant; FDA and regulatory uncertainties and risks; the significant expense, time and risk of failure of conducting clinical trials; the need for Celsion to evaluate its future development plans; possible acquisitions or licenses of other technologies, assets or businesses; possible actions by customers, suppliers, competitors or regulatory authorities; and other risks detailed from time to time in the Celsion's periodic filings with the Securities and Exchange Commission. Celsion assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise. Celsion Investor ContactJeffrey W. ChurchExecutive Vice President and CFO609firstname.lastname@example.org LHA Investor RelationsKim Sutton Golodetz212email@example.com # # #
CHARLOTTE, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Capitala Group (“Capitala”), a provider of capital to lower middle market companies, announced today that it closed on an investment in Fremont-Wright, LLC (“Fremont-Wright”). Capitala partnered with SouthWorth Capital Management, LLC (“SouthWorth Capital”) on the transaction in support of Fremont-Wright’s next phase of growth. Based in Memphis, TN, Fremont-Wright is a holding company comprised of nine entities that provide engineering, surveying, and architectural services. The company leverages local expertise combined with national reach to deliver service across eleven states. “We are enthusiastic about working with SouthWorth Capital again and look forward to participating in Fremont-Wright’s growth as they continue to look for suitable acquisitions in their target markets,” stated Jack McGlinn, Senior Managing Director at Capitala Group. About Capitala Group Capitala Group is an asset management firm that has been providing capital to lower middle market companies throughout North America for over twenty years. Since our inception in 1998, Capitala has invested over $2.0 billion in approximately 170 companies and seeks to partner with strong management teams to create value and aims to generate superior risk-adjusted returns for our individual and institutional investors. For more information, definitions and details visit our website at www.CapitalaGroup.com. Contacts: Steve Arnall CFO | Investor Relations firstname.lastname@example.org Katina Cole JakubowskiMarketing | Communications email@example.com
The process of taking a company public via a SPAC, or special purpose acquisition company, is very different from an initial public offering (IPO). Investors would be well-served to research special purpose acquisition companies and make some small investments in exciting rule-breakers that are going public in this rule-breaking way.
Score Media and Gaming (TSX:SCR) or theScore stock looks ripe for buying after its latest pullback alongside the growthiest tech stocks. The post theScore (TSX:SCR) Stock Looks More Attractive Than Bitcoin or Tesla appeared first on The Motley Fool Canada.
Aly Goni and Jasmin Bhasin bonded while shooting for Fear Factor: Khatron Ke Khiladi 9 in Argentina and became close friends. During their stint in Bigg Boss 14, the couple confessed being in love with each other.
Princess Shamsa was abducted from the streets of Cambridge on August 19 2000 and has not been seen in public since.
Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Global Next Gen Learning Management System (LMS) Market for Higher Education Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The next gen learning management system (LMS) market for higher education is poised to grow by $ 3.04 bn, progressing at a CAGR of 29% during the forecast period. The market is driven by the need for cost-effective LMS for higher education and enhanced content management features. The report on next gen learning management system (LMS) market for higher education provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The next gen learning management system (LMS) market for higher education analysis includes application segment and geographic landscape.This study identifies inclusion of analytics in LMS as one of the prime reasons driving the next gen learning management system (LMS) market for higher education growth during the next few years.The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading next gen learning management system (LMS) market for higher education vendors that include Blackboard Inc., D2L Corp., Docebo Inc., Edmodo, Growth Engineering, Instructure Inc., Jenzabar Inc., N2N Services Inc., PowerSchool Group LLC, and Saba Software Inc. Also, the next gen learning management system (LMS) market for higher education analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.Key Topics Covered: Executive Summary Market Overview Market Landscape Market ecosystemValue chain analysis Market Sizing Market definitionMarket segment analysisMarket size 2019Market outlook: Forecast for 2019 - 2024 Five Forces Analysis Five Forces SummaryBargaining power of buyersBargaining power of suppliersThreat of new entrantsThreat of substitutesThreat of rivalryMarket condition Market Segmentation by Application Market segmentsComparison by ApplicationBlended learning - Market size and forecast 2019-2024Content management - Market size and forecast 2019-2024CBE - Market size and forecast 2019-2024Learning analytics - Market size and forecast 2019-2024Market opportunity by Application Customer landscape Overview Geographic Landscape Geographic segmentationGeographic comparisonNorth America - Market size and forecast 2019-2024Europe - Market size and forecast 2019-2024APAC - Market size and forecast 2019-2024South America - Market size and forecast 2019-2024MEA - Market size and forecast 2019-2024Key leading countriesMarket opportunity by geographyMarket driversMarket challengesMarket trends Vendor Landscape OverviewVendor landscapeLandscape disruption Vendor Analysis Vendors coveredMarket positioning of vendorsBlackboard Inc.D2L Corp.Docebo Inc.EdmodoGrowth EngineeringInstructure Inc.Jenzabar Inc.N2N Services Inc.PowerSchool Group LLCSaba Software Inc. AppendixFor more information about this report visit https://www.researchandmarkets.com/r/cr4r8k CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
According to Precedence Research, the global flow meters market size is projected to hit around US$ 12.5 billion by 2027 with a CAGR of 5.6% from 2020 to 2027OTTAWA, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The global flow meters market size accounted at US$ 7.9 billion in 2019, according to new report study. A flow meter is an instrument that is used to measure the nonlinear, linear, volumetric or mass flow of a gas or liquid. Flow meters are also known by many other names, such as flow indicator, flow gauge, flow rate sensor, liquid meter, etc. depending on the particular industry. Besides this, they all are used to measure the flow. Open channels, like streams or rivers can also be measured using flow meters. Flow meter sensor work in various ways but have same goal to provide repeated and most accurate flow measurement for specific applications. Some of the commonly used flow meters in industries include obstruction type, inferential or turbine type, electromagnetic, positive displacement flow meter, anemometer, ultrasonic, coriolis, and vortex. Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1069 Growth Factors The flow meter market is a matured market; however still in its development phase and expected to offer prominent growth opportunities in the coming years. The implementation of flow meters is highly preferred in the process industries. In addition, the governments of different regions have mandated the use of flow meters owing to numerous advantages associated with them. Oil & gas, water and wastewater, power generation, chemical, and pulp & paper are some of the major consumers of flow meter. Thus, factors such as rise in industrial output, increase in the number of initiatives to construct safe water management infrastructure, and surge in energy needs primarily boost the demand for flow meters. Report Highlights In 2019, Europe led the global market in terms of revenue followed by North America due to rising adoption of flow meters in the power generation sectorThe Asia Pacific encountered as the most lucrative region with a growth rate of around 7% during the analysis period due to continuous development in the water & wastewater industryBased on product, magnetic segment led the global market in the year 2019 due to its increased application in numerous industries.Coriolis and ultrasonic segments anticipated to register the highest growth over the analysis period owing to their advanced features that allow the integration of IoTOil & gas expected to witness a prominent growth rate over the analysis period owing to development of shale gas reserves and other prominent developments in the sectorWater & wastewater application captured nearly 23% of the value share in 2019 and expected to register a CAGR exceeding 6% during the forecast period Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1069 Regional Snapshots Europe led the global flow meters market in terms of revenue share, followed by the North America. Presence of prominent market players in the region such as Diehl Metering Germany, Endress+Hausar AG, ABB, and KROHNE Messtechnik accounted for the prominent growth of the region. Furthermore, rising government investment on the water treatment plants again spur the demand for flow meters in the region. Rising population and introduction of new and advanced technologies have prominently boosted the growth of power generation, water supply, usage of chemicals, and water treatment and management system, thereby fuelling the growth of the flow meters market. On the other hand, the Asia Pacific encountered the fastest growth over the analysis period owing to rising demand for reliable and high-quality measurement tools from various end-use industries. Further, the region is a global leader in the chemical production and import & export activity. This significantly triggers the demand for flow meters in various industries as chemicals are widely used in industrial applications. Increasing demand for oil & gas along with water supply management and treatment plants in the region accounted for the other most prominent factor to propel the growth of flow meters in the region. Related Reports Supercapacitors Market - The global market size was surpassed US$ 3.5 billion in 2019 and expected to hit US$ 15.9 billion by 2027 growing at a CAGR of 23.2% from year 2020 to 2027.Microcontroller (MCU) Market - The global market was valued at USD 21.49 Billion in 2019 and expected to reach USD 48.11 Billion by 2027 and poised to grow at a CAGR 10.6% during the forecast period 2020 to 2027.Compound Semiconductor Market - The global market value surpassed USD 32.5 Billion in 2019 and expected to hit over USD 44.52 billion by 2027 with a registered CAGR of around 6.2% during the forecast period 2020 to 2027. Key Players & Strategies Prominent market players in the global flow meters market have adopted merger & acquisition strategy to expand their regional presence. Further, these companies also focus prominently on the advanced and new product development to gain a competitive edge by offering differentiated product in the market. In the wake of same, the market players invest notably in the research & development sector. Furthermore, rising adoption of intelligent and advanced flow meters in the water & wastewater, chemicals, and oil & gas industry offer lucrative opportunity to the market players to uplift their market position by meeting their requirement. Some of the key players operating in the market areEmerson Electric Co., ABB Ltd., em-tec GmbH, General Electric, Endress+Hauser Management AG, Hitachi, Ltd., Höntzsch GmbH, Honeywell International, Inc., KROHNE Messtechnik GmbH, VSE Volumentechnik GmbH, Siemens, and Yokogawa Electric Corporation among others. By Product Positive Displacement (PD)Differential Pressure (DP)VortexUltrasonicMagnetic WirelessWired TurbineCoriolisOthers By Application Oil & GasWater & WastewaterPower GenerationChemicalsFood & BeveragePulp & PaperOthers By Regional Outlook North America U.S.Canada Europe U.K.GermanyFrance Asia Pacific ChinaIndiaJapanSouth Korea Rest of the World Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1069 You can place an order or ask any questions, please feel free to contact at email@example.com | +1 774 402 6168 About Us Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. For Latest Update Follow Us: https://www.linkedin.com/company/precedence-research/ https://www.facebook.com/precedenceresearch/ https://twitter.com/Precedence_R